Processing

Please wait...

Settings

Settings

Goto Application

1. WO2000012484 - TAN-1057 DERIVATIVES

Publication Number WO/2000/012484
Publication Date 09.03.2000
International Application No. PCT/EP1999/006124
International Filing Date 20.08.1999
Chapter 2 Demand Filed 15.02.2000
IPC
A61K 31/41 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
A61K 31/495 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
A61K 31/505 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
A61K 31/513 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
513having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
A61K 31/53 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
53having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
A61P 31/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
CPC
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
C07D 239/22
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
02not condensed with other rings
20having two double bonds between ring members or between ring members and non-ring members
22with hetero atoms directly attached to ring carbon atoms
C07D 401/02
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02containing two hetero rings
C07D 403/02
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
403Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
02containing two hetero rings
Applicants
  • BAYER AKTIENGESELLSCHAFT [DE]/[DE] (AllExceptUS)
  • BRANDS, Michael [DE]/[DE] (UsOnly)
  • ES-SAYED, Mazen [DE]/[DE] (UsOnly)
  • HÄBICH, Dieter [DE]/[DE] (UsOnly)
  • RADDATZ, Siegfried [DE]/[DE] (UsOnly)
  • KRÜGER, Joachim [DE]/[DE] (UsOnly)
  • ENDERMANN, Rainer [DE]/[DE] (UsOnly)
  • GAHLMANN, Reinhold [DE]/[DE] (UsOnly)
  • KROLL, Hein-Peter [DE]/[DE] (UsOnly)
  • GESCHKE, Frank-Ulrich [DE]/[DE] (UsOnly)
  • DE MEIJERE, Armin [DE]/[DE] (UsOnly)
  • BELOV, Vladimir N. [RU]/[RU] (UsOnly)
  • SOKOLOV, Victor [RU]/[RU] (UsOnly)
  • KOZHUSHKOV, Sergej [RU]/[DE] (UsOnly)
  • KORDES, Markus [DE]/[DE] (UsOnly)
Inventors
  • BRANDS, Michael
  • ES-SAYED, Mazen
  • HÄBICH, Dieter
  • RADDATZ, Siegfried
  • KRÜGER, Joachim
  • ENDERMANN, Rainer
  • GAHLMANN, Reinhold
  • KROLL, Hein-Peter
  • GESCHKE, Frank-Ulrich
  • DE MEIJERE, Armin
  • BELOV, Vladimir N.
  • SOKOLOV, Victor
  • KOZHUSHKOV, Sergej
  • KORDES, Markus
Priority Data
198 38 998.127.08.1998DE
Publication Language German (DE)
Filing Language German (DE)
Designated States
Title
(DE) TAN-1057 DERIVATE
(EN) TAN-1057 DERIVATIVES
(FR) DERIVES DE TAN 1057
Abstract
(DE)
Die Erfindung betrifft neue Naturstoffderivate, Verfahren zu ihrer Herstellung, sie umfassende pharmazeutische Zusammensetzungen sowie ihre Verwendung bei der Behandlung von Erkrankungen bei Menschen oder Tieren.
(EN)
The invention relates to novel derivatives of natural substances, to a method for producing said derivatives, to pharmaceutical compositions containing them and to their use in the treatment of diseases in humans and animals.
(FR)
L'invention concerne de nouveaux dérivés de substances naturelles, des procédés pour leur préparation, des compositions pharmaceutiques les contenant ainsi que leur utilisation lors du traitement de maladies chez l'homme et les animaux.
Also published as
HRP20010135A
ININ/PCT/2001/00165/MUM
NO20010940
TR2001/00637
ZA200101038
Latest bibliographic data on file with the International Bureau